HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research

Ralf Hofheinz1, Sylvie Lorenzen2, Michael K Bohlmann3

  • 1Mannheim Cancer Center, University Hospital Mannheim, University of Heidelberg, 68167 Mannheim, Germany.

Cancers
|July 14, 2023
PubMed

Insights

Trastuzumab, a targeted therapy for HER2-positive breast cancer, has been available for nearly 25 years. This therapy has significantly impacted treatment for patients with metastatic disease.

Area of Science:

  • Oncology
  • Immunotherapy
  • Pharmacology

Background:

  • Trastuzumab, a monoclonal antibody, targets human epidermal growth factor receptor 2 (HER2).
  • It was approved in the USA nearly 25 years ago for metastatic HER2-positive breast cancer.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K